Central nervous system melanocytic neoplasm
diseaseOn this page
Also known as central nervous system melanocytic neoplasmscentral nervous system melanocytic tumorcentral nervous system melanocytic tumourCNS melanocytic neoplasmCNS melanocytic tumorCNS melanocytic tumourmelanocytic neoplasm of central nervous systemmelanocytic neoplasm of CNSmelanocytic neoplasm of the central nervous systemmelanocytic neoplasm of the CNSmelanocytic tumor of central nervous systemmelanocytic tumor of CNSmelanocytic tumor of the central nervous systemmelanocytic tumour of central nervous systemmelanocytic tumour of CNSmelanocytic tumour of the central nervous systemmelanocytic tumour of the CNS
Summary
Central nervous system melanocytic neoplasm (MONDO:0003222) is a cancer and 1 clinical trial. A subtype of central nervous system cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | central nervous system melanocytic neoplasm |
| Mondo ID | MONDO:0003222 |
| DOID | DOID:4955 |
| NCIT | C5504 |
| SNOMED CT | 277523004 |
| UMLS | C5670969 |
| MedGen | 1809168 |
| GARD | 0009422 |
| Anatomy (UBERON) | UBERON:0001017 |
| Is cancer (heuristic) | yes |
Also known as: central nervous system melanocytic neoplasm · central nervous system melanocytic neoplasms · central nervous system melanocytic tumor · central nervous system melanocytic tumour · CNS melanocytic neoplasm · CNS melanocytic tumor · CNS melanocytic tumour · melanocytic neoplasm of central nervous system · melanocytic neoplasm of CNS · melanocytic neoplasm of the central nervous system · melanocytic neoplasm of the CNS · melanocytic tumor of central nervous system · melanocytic tumor of CNS · melanocytic tumor of the central nervous system · melanocytic tumour of central nervous system · melanocytic tumour of CNS · melanocytic tumour of the central nervous system · melanocytic tumour of the CNS
Disease family
This is a subtype of central nervous system cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › central nervous system melanocytic neoplasm
Related subtypes (19): central nervous system primitive neuroectodermal neoplasm, brain cancer, central nervous system sarcoma, primary central nervous system lymphoma, central nervous system germinoma, central nervous system endodermal sinus tumor, spinal cord cancer, malignant carotid body paraganglioma, malignant adrenal gland pheochromocytoma, malignant jugulotympanic paraganglioma, pheochromocytoma/paraganglioma syndrome 2, pheochromocytoma/paraganglioma syndrome 5, central nervous system Ewing sarcoma/peripheral primitive neuroectodermal tumor, choriocarcinoma of the central nervous system, mixed germ cell tumor of central nervous system, embryonal carcinoma of the central nervous system, malignant tumor of meninges, malignant central nervous system mesenchymal, non-meningothelial neoplasm, malignant glioma
Subtypes (3): diffuse meningeal melanocytosis, meningeal melanocytoma, primary melanoma of the central nervous system
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05259605 | Not specified | RECRUITING | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.